rs1800579

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000361.3(THBD):​c.1502C>T​(p.Pro501Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00268 in 1,608,780 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0028 ( 9 hom. )

Consequence

THBD
NM_000361.3 missense

Scores

7
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:6

Conservation

PhyloP100: 4.11
Variant links:
Genes affected
THBD (HGNC:11784): (thrombomodulin) The protein encoded by this intronless gene is an endothelial-specific type I membrane receptor that binds thrombin. This binding results in the activation of protein C, which degrades clotting factors Va and VIIIa and reduces the amount of thrombin generated. Mutations in this gene are a cause of thromboembolic disease, also known as inherited thrombophilia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056052804).
BP6
Variant 20-23048003-G-A is Benign according to our data. Variant chr20-23048003-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 337882.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=1, Benign=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00193 (294/152358) while in subpopulation NFE AF= 0.00301 (205/68028). AF 95% confidence interval is 0.00268. There are 0 homozygotes in gnomad4. There are 137 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 294 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
THBDNM_000361.3 linkuse as main transcriptc.1502C>T p.Pro501Leu missense_variant 1/1 ENST00000377103.3 NP_000352.1 P07204

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
THBDENST00000377103.3 linkuse as main transcriptc.1502C>T p.Pro501Leu missense_variant 1/16 NM_000361.3 ENSP00000366307.2 P07204

Frequencies

GnomAD3 genomes
AF:
0.00193
AC:
294
AN:
152240
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00301
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00180
AC:
422
AN:
234646
Hom.:
1
AF XY:
0.00184
AC XY:
236
AN XY:
127946
show subpopulations
Gnomad AFR exome
AF:
0.000283
Gnomad AMR exome
AF:
0.00102
Gnomad ASJ exome
AF:
0.00187
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000674
Gnomad FIN exome
AF:
0.00105
Gnomad NFE exome
AF:
0.00300
Gnomad OTH exome
AF:
0.00191
GnomAD4 exome
AF:
0.00275
AC:
4010
AN:
1456422
Hom.:
9
Cov.:
30
AF XY:
0.00276
AC XY:
1996
AN XY:
724188
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.00107
Gnomad4 ASJ exome
AF:
0.00174
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000666
Gnomad4 FIN exome
AF:
0.00132
Gnomad4 NFE exome
AF:
0.00332
Gnomad4 OTH exome
AF:
0.00170
GnomAD4 genome
AF:
0.00193
AC:
294
AN:
152358
Hom.:
0
Cov.:
33
AF XY:
0.00184
AC XY:
137
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.000457
Gnomad4 AMR
AF:
0.00268
Gnomad4 ASJ
AF:
0.00288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00104
Gnomad4 NFE
AF:
0.00301
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00286
Hom.:
2
Bravo
AF:
0.00201
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.00137
AC:
6
ESP6500EA
AF:
0.00292
AC:
25
ExAC
AF:
0.00178
AC:
215

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:2
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicNov 30, 2022PS3_moderate -
Uncertain significance, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
Uncertain significance, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2024THBD: BP4, BS1 -
Thrombomodulin-related bleeding disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology-- -
Thrombocytopenia;C1458140:Abnormal bleeding Uncertain:1
Uncertain significance, no assertion criteria providedresearchBirmingham Platelet Group; University of BirminghamMay 01, 2020- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 06, 2024- -
THBD-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 04, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Atypical hemolytic-uremic syndrome with thrombomodulin anomaly Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Atypical hemolytic-uremic syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJun 01, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.58
D
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.32
FATHMM_MKL
Benign
0.52
D
LIST_S2
Benign
0.60
T
M_CAP
Uncertain
0.22
D
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-0.55
T
MutationAssessor
Uncertain
2.4
M
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-3.6
D
REVEL
Benign
0.26
Sift
Uncertain
0.012
D
Sift4G
Uncertain
0.021
D
Polyphen
0.67
P
Vest4
0.28
MVP
0.52
ClinPred
0.034
T
GERP RS
4.2
Varity_R
0.13
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1800579; hg19: chr20-23028640; COSMIC: COSV101001861; API